ArticleCellular and molecular life sciences : CMLS2025
PROM2 exacerbates CCl4-Induced liver fibrosis via NLRP3 inflammasome activation and hepatocyte pyroptosis.
Article in Cellular and molecular life sciences : CMLS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundLiver fibrosis is a progressive disorder resulting from chronic liver injury, and its molecular mechanism remains incompletely elucidated.
methodsThe role of PROM2 was assessed by integrating transcriptomic datasets with in vivo liver fibrosis models. Functional analyses were performed using PROM2 knockdown or overexpression strategies, along with NLRP3 knockout models, to investigate its mechanistic involvement in epithelial-mesenchymal transition (EMT) and inflammasome activation.
resultsTranscriptomic analysis revealed that PROM2 expression was significantly upregulated in fibrotic livers and positively correlated with fibrosis- and EMT-related gene signatures. PROM2 knockdown significantly attenuated hepatic inflammation, inhibited EMT, and reduced fibrotic remodeling. In contrast, PROM2 overexpression aggravated these pathological features. Notably, in NLRP3-deficient mice, PROM2 overexpression failed to induce inflammation, EMT, or fibrosis, indicating that the pro-fibrotic effects of PROM2 are mediated through NLRP3 signaling.
conclusionPROM2 contributes to liver fibrosis by promoting EMT and activating NLRP3-dependent inflammatory pathways, suggesting it as a potential therapeutic target for liver fibrosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.